‘Female Viagra’ Effective for Breast Cancer Patients on Tamoxifen – Medpage Today

The use of flibanserin (Addyi) in women with breast cancer was associated with improvements in medically and treatment-induced decreased libido, according to a study presented at the American Society of Clinical Oncology (ASCO) annual meeting. In this exclusive MedPage Today video, Halle Moore, MD, of the Cleveland Clinic’s Taussig Cancer Institute in Ohio, discussed the…

Read More